Nobuyo Higashi‐Kuwata

Statistics

Publications

Citations

819

H-Index

Active since

2010

Affiliations

National Center for Global Health and Medicine(Current)

National Cancer Institute

Kumamoto University Hospital

Kumamoto University

National Institutes of Health

Nobuyo Higashi‐Kuwata is an author at National Center for Global Health and Medicine specializing in pharmacology, antiviral pharmacology, and medicinal chemistry.

ORCID

Publications per year

2010–2024

Publications

Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis

Nobuyo Higashi‐Kuwata, Masatoshi Jinnin, Takamitsu Makino et al. · Arthritis Research & Therapy · 2010 · 246 citations · Full text

Medicine, Immunology, Pathology +17

A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication

Shin-ichiro Hattori, Nobuyo Higashi‐Kuwata, Hironori Hayashi et al. · Nature Communications · 2021 · 192 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma

Kenji Maeda, Nobuyo Higashi‐Kuwata, Noriko Kinoshita et al. · Scientific Reports · 2021 · 54 citations · Full text

Life Sciences, Immunology, Infectious Diseases +13

A novel central nervous system-penetrating protease inhibitor overcomes human immunodeficiency virus 1 resistance with unprecedented aM to pM potency

Manabu Aoki, Hironori Hayashi, Kalapala Venkateswara Rao et al. · eLife · 2017 · 53 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

4′‐modified nucleoside analogs: Potent inhibitors active against entecavir‐resistant hepatitis B virus

Yuki Takamatsu, Yasuhito Tanaka, Satoru Kohgo et al. · Hepatology · 2015 · 52 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

1–5 of 16